[go: up one dir, main page]

SV2001000085A - Suspension de ziprasidona ref. pc10509ajtj/bb - Google Patents

Suspension de ziprasidona ref. pc10509ajtj/bb

Info

Publication number
SV2001000085A
SV2001000085A SV2000000085A SV2000000085A SV2001000085A SV 2001000085 A SV2001000085 A SV 2001000085A SV 2000000085 A SV2000000085 A SV 2000000085A SV 2000000085 A SV2000000085 A SV 2000000085A SV 2001000085 A SV2001000085 A SV 2001000085A
Authority
SV
El Salvador
Prior art keywords
ref
ziprasidone
suspension
diaxide
ziprasidone suspension
Prior art date
Application number
SV2000000085A
Other languages
English (en)
Inventor
Daniel Ray Arenson
Hong Qi
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22472103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2001000085(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SV2001000085A publication Critical patent/SV2001000085A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Dental Preparations (AREA)
  • Cosmetics (AREA)
  • Colloid Chemistry (AREA)

Abstract

LAS COMPOSICIONES SE REFIEREN A UNA SUSPENSION ORAL QUE COMPRENDEN LA BASE LIBRE DE ZIPRASIDONA O UNA SAL DE ADICION DE ACIDOS DE ZIPRASIONA FARMACEUTICAMENTE ACEPTABLE DIFICIL DE HUMECTAR, UN POLISORBATO, DIOXIDO DE SILICIO COLOIDAL FORMAN BUENAS SUSPENSIONES ACUOSAS QUE TIENEN UNA DURACION LARGA Y SON FACILES DE RESUSPENDER SI SE PRODUCE SEDIMENTACION.
SV2000000085A 1999-05-27 2000-05-26 Suspension de ziprasidona ref. pc10509ajtj/bb SV2001000085A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13626899P 1999-05-27 1999-05-27

Publications (1)

Publication Number Publication Date
SV2001000085A true SV2001000085A (es) 2001-11-08

Family

ID=22472103

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2000000085A SV2001000085A (es) 1999-05-27 2000-05-26 Suspension de ziprasidona ref. pc10509ajtj/bb

Country Status (50)

Country Link
EP (1) EP1181018B1 (es)
JP (1) JP3942827B2 (es)
KR (1) KR100477782B1 (es)
CN (1) CN1196486C (es)
AP (1) AP1409A (es)
AR (1) AR022643A1 (es)
AT (1) ATE234097T1 (es)
AU (1) AU777413B2 (es)
BG (1) BG65367B1 (es)
BR (1) BR0010990A (es)
CA (1) CA2371550C (es)
CO (1) CO5170458A1 (es)
CR (1) CR6506A (es)
CU (1) CU23223B7 (es)
CZ (1) CZ20014230A3 (es)
DE (1) DE60001649T2 (es)
DK (1) DK1181018T3 (es)
DZ (1) DZ3049A1 (es)
EA (1) EA003907B1 (es)
EE (1) EE04704B1 (es)
ES (1) ES2191618T3 (es)
GC (1) GC0000190A (es)
GE (1) GEP20033113B (es)
GT (1) GT200000081A (es)
HK (1) HK1046366B (es)
HN (1) HN2000000071A (es)
HR (1) HRP20010878B1 (es)
HU (1) HUP0201297A3 (es)
IL (2) IL145950A0 (es)
IS (1) IS2396B (es)
MA (1) MA26741A1 (es)
MX (1) MXPA01012124A (es)
MY (1) MY127891A (es)
NO (1) NO320296B1 (es)
NZ (1) NZ514764A (es)
OA (1) OA11946A (es)
PA (1) PA8495801A1 (es)
PE (1) PE20010127A1 (es)
PL (1) PL196867B1 (es)
RS (1) RS50089B (es)
SI (1) SI1181018T1 (es)
SK (1) SK284590B6 (es)
SV (1) SV2001000085A (es)
TN (1) TNSN00112A1 (es)
TR (1) TR200103392T2 (es)
TW (1) TWI263498B (es)
UA (1) UA59491C2 (es)
UY (1) UY26166A1 (es)
WO (1) WO2000072847A1 (es)
ZA (1) ZA200109692B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7175855B1 (en) 1999-05-27 2007-02-13 Pfizer Inc. Ziprasidone suspension
WO2001032148A1 (en) 1999-10-29 2001-05-10 Euro-Celtique, S.A. Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
CN101317825A (zh) 2000-10-30 2008-12-10 欧罗赛铁克股份有限公司 控释氢可酮制剂
JP4619658B2 (ja) * 2002-03-12 2011-01-26 富山化学工業株式会社 快い味の経口懸濁液および方法
MXPA05002561A (es) * 2002-10-25 2005-05-05 Pfizer Prod Inc Nuevas formulaciones de liberacion prolongada inyectables.
KR20050071611A (ko) * 2002-10-25 2005-07-07 화이자 프로덕츠 인코포레이티드 현탁액 형태의 아릴헤테로환 활성제의 저장 제형
MXPA03009945A (es) 2002-11-05 2007-04-16 Lg Electronics Inc Montaje para montar una pantalla de toque para un monitor con pantalla de cristal liquido.
EP1628973A2 (en) 2003-10-24 2006-03-01 Teva Pharmaceutical Industries Ltd. Processes for preparation of ziprasidone
WO2005107719A2 (en) 2004-05-06 2005-11-17 Sandoz Ag Pharmaceutical composition comprising hydrophobic drug having improved solubility
WO2005123086A2 (en) * 2004-06-11 2005-12-29 Dr. Reddy's Laboratories Ltd. Ziprasidone dosage form
US20080268034A1 (en) * 2005-01-07 2008-10-30 Girish Karanth Solid Oral Dosage Forms of Ziprasidone Containing Colloidal Silicone Dioxide
EP1901722A4 (en) * 2005-06-20 2011-06-15 Elan Pharma Int Ltd NANOTEHOUS COMPOSITIONS WITH CONTROLLED RELEASE FROM ARYL-HETEROCYCLIC COMPOUNDS
EP1906937B1 (en) 2005-07-22 2016-10-19 Rubicon Research Pvt Ltd. Novel dispersible tablet composition
CN100391458C (zh) * 2006-02-07 2008-06-04 上海医药工业研究院 齐拉西酮或其盐包合物制备方法
KR20080076667A (ko) * 2007-02-15 2008-08-20 주식회사 중외제약 요변성 약학 조성물
JP4336380B1 (ja) * 2008-11-06 2009-09-30 塩野義製薬株式会社 水懸濁性を向上させた細粒剤
JP6272730B2 (ja) * 2014-05-21 2018-01-31 救急薬品工業株式会社 速溶性フィルム剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US5312925A (en) * 1992-09-01 1994-05-17 Pfizer Inc. Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride
US6150366A (en) * 1998-06-15 2000-11-21 Pfizer Inc. Ziprasidone formulations

Also Published As

Publication number Publication date
PA8495801A1 (es) 2001-12-14
NO320296B1 (no) 2005-11-21
CN1196486C (zh) 2005-04-13
EE200100633A (et) 2003-02-17
EP1181018B1 (en) 2003-03-12
CA2371550A1 (en) 2000-12-07
SK16782001A3 (sk) 2002-09-10
HN2000000071A (es) 2001-02-02
SK284590B6 (sk) 2005-07-01
AU4138500A (en) 2000-12-18
EP1181018A1 (en) 2002-02-27
GEP20033113B (en) 2003-11-25
ES2191618T3 (es) 2003-09-16
EE04704B1 (et) 2006-10-16
IL145950A0 (en) 2002-07-25
TR200103392T2 (tr) 2002-11-21
PL196867B1 (pl) 2008-02-29
RS50089B (sr) 2009-01-22
AU777413B2 (en) 2004-10-14
IL145950A (en) 2007-12-03
BG65367B1 (bg) 2008-04-30
UY26166A1 (es) 2000-12-29
EA003907B1 (ru) 2003-10-30
MY127891A (en) 2006-12-29
AR022643A1 (es) 2002-09-04
DE60001649D1 (de) 2003-04-17
NO20015755D0 (no) 2001-11-26
JP3942827B2 (ja) 2007-07-11
HK1046366B (zh) 2005-07-29
KR100477782B1 (ko) 2005-03-21
CO5170458A1 (es) 2002-06-27
HUP0201297A2 (en) 2002-08-28
DK1181018T3 (da) 2003-04-22
ZA200109692B (en) 2002-11-26
DE60001649T2 (de) 2003-08-21
AP2001002346A0 (en) 2001-12-31
CU23223B7 (es) 2007-08-30
PE20010127A1 (es) 2001-02-06
TNSN00112A1 (fr) 2005-11-10
GT200000081A (es) 2001-11-16
BG106153A (bg) 2002-06-28
PL352826A1 (en) 2003-09-08
GC0000190A (en) 2006-03-29
MA26741A1 (fr) 2004-12-20
HRP20010878A2 (en) 2003-06-30
CN1352560A (zh) 2002-06-05
CR6506A (es) 2004-03-24
UA59491C2 (uk) 2003-09-15
HK1046366A1 (en) 2003-01-10
IS2396B (is) 2008-08-15
EA200101131A1 (ru) 2002-04-25
IS6134A (is) 2001-10-30
OA11946A (en) 2006-04-13
CA2371550C (en) 2007-01-02
KR20020048307A (ko) 2002-06-22
MXPA01012124A (es) 2002-06-04
AP1409A (en) 2005-06-13
HUP0201297A3 (en) 2005-09-28
BR0010990A (pt) 2002-03-05
CZ20014230A3 (cs) 2002-08-14
HRP20010878B1 (en) 2007-03-31
ATE234097T1 (de) 2003-03-15
NO20015755L (no) 2002-01-23
DZ3049A1 (fr) 2004-03-27
SI1181018T1 (en) 2003-06-30
YU76701A (sh) 2005-07-19
NZ514764A (en) 2004-04-30
JP2003500449A (ja) 2003-01-07
TWI263498B (en) 2006-10-11
WO2000072847A1 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
SV2001000085A (es) Suspension de ziprasidona ref. pc10509ajtj/bb
FR20C1039I2 (fr) Derives de l'uk-2a
ITRM950377A0 (it) Strumento endodontico per l'allargamento meccanico rapido dell'imboccocanalare e la rettificazione mirata dei primi due terzi.
RU2002112227A (ru) Производные пятичленных гетероциклов, способ их получения и их применение в качестве лекарственных средств
EP1109532A4 (en) Oral micro-emulsion composition of silybin
ATE289478T1 (de) Ektoparasitizide wässrige suspensionsformulierungen von spinosynen
DE50014207D1 (de) Dentalinstrument
ATE302004T1 (de) Stabile orale zusammensetzung enthaltend benzimidazol derivate
FR2847899B1 (fr) Derives d'indole-3-carboxamide, leur preparation et leur application en therapeutique
DE60132511D1 (de) E-isomeren von fullerenderivate
BR0011261B1 (pt) composiÇço oral compreendendo perlita, e, uso de perlita.
DE69828390D1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
ITMI20011633A0 (it) Uso di polisaccaridi batterici supersolfatati inibitori dell'hiv
EP1565162A4 (en) MICROEMULSION COMPOSITION FOR ORAL ADMINISTRATION OF BIPHENYLDIMETHYLDICARBOXYLATE
WO2001037780A8 (en) Urotensin-ii analogs
FI20002452A0 (fi) Menetelmät hammashoitokoneen vesilinjojen desinfioimiseksi ja hammashoitokoneen vesilinjojen desinfiointijärjestelyt
ECSP003496A (es) Suspensión de ziprasidona
DE60037197D1 (de) Verwendung funktioneller oraler präparate
DE10084448T1 (de) Selbstkompensierender Ausgangspuffer
FR2829136B1 (fr) Derives lipidiques d'aminoglycosides
JP2002519670A5 (ja) Ｃ型レトロウイルス感染の検出のための方法および組成物
IT249694Y1 (it) Vite endossea parzialmente sommersa particolarmente progettata per l'implantologia dentale
IT1312459B1 (it) Sassofono modificato ad elevata semplicita' di impiego
IT1305295B1 (it) Schede incisali, riproducenti le caratteristiche fisico cromatichepiu' frequenti nella dentatura dell'uomo, e metodo per il loro
IT1310353B1 (it) Articolatore per la riproduzione degli spostamenti mascellari per larealizzazione di protesi dentarie con accoppiamento condilare

Legal Events

Date Code Title Description
FD Lapse